<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20200424</date><key>pmc.key</key><document><id>4352710</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.4172/2161-038X.1000139</infon><infon key="article-id_manuscript">NIHMS666579</infon><infon key="article-id_pmc">4352710</infon><infon key="article-id_pmid">25763298</infon><infon key="fpage">1000139</infon><infon key="issue">3</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</infon><infon key="name_0">surname:Scovell;given-names:Jason M</infon><infon key="name_1">surname:Ramasamy;given-names:Ranjith</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">3</infon><infon key="year">2015</infon><offset>0</offset><text>Should Men Take Prenatal Vitamins?</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>35</offset><text>Short Communication</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>55</offset><text>Congenital abnormalities are the leading cause of infant mortalities in the United States (25%) and across the world. Public health interventions have included reducing maternal disease, prenatal care of mothers, reduction of exposure to teratogens (agent that can disturb the development of an embryo or fetus), and nutritional interventions. Potentially the most significant nutritional intervention has been the prenatal supplementation of folate, which has been shown to reduce the incidence of neural tube defects, limb malformations, urogenital abnormalities, cardiovascular malformations, and cleft lip or palate.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>676</offset><text>The influence of paternal diet on congenital abnormalities and fertility is still being elucidated. A recent mouse study by Lambrot et al. furthered our understanding of the effects of paternal folate deficiency. Mice were fed a Folate Deficient (FD) or Folate Sufficient (FS) diet, and were assessed for birth defects. Additionally, genome-wide and spermatic methylation studies were performed. Folate deficiency was associated with an increase in DNA damage in spermatocytes. However, there was no difference in sperm tail DNA fragmentation, tail length, or motility (p&gt;0.05). Mice fed with a folate deficient diet were less fertile (52% vs. 85%) and experienced a greater post-implantation loss than mice fathered by mice with a folate sufficient diet. Gross anatomical abnormalities were greater in mice fathered by FD mice (27% vs. 3%) which included craniofacial, hydrocephalus, limb, and muscle/skeletal defects. Another study investigating the effect of a paternal folate-deficient diet in mice found a relationship with decreased placental weight, placental folate and an increased expression of the folate transporter folate receptor.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1821</offset><text>A link has been found between paternal dioxin exposure, a component of the herbicide Agent Orange used in the Vietnam War, and spermatazoidfolate deficiency resulting in an increased rate of spina bifida. Although the precise mechanism is unclear, it is thought that epigenetic modifications (study of heritable changes in gene activity that are not caused by changes in the DNA sequence) play a role in both neural tube defects and decreased fertility of men with a folate deficiency. However, a prospective study of 42 couples, who had paternal methotrxate exposure at the time of conception, did not identify any congenital abnormalities. In the literature, 2 out of 23 children fathered by men on methotrexate were found to have congenital abnormalities. The role of paternal nutrition on epigenetically linked heritable diseases such as cardiovascular and obesity have been suggested in epidemiological studies.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2738</offset><text>Human studies examining the role of paternal micronutrient supplementation are scant. In 2008, Young et al. investigated the role of supplemental folate, zinc and antioxidants (vitamins C, E, and Î²-carotene) on spermatocyte aneuploidy. Men consuming the most folate (&gt;75th percentile) had a lower frequency of disomy 21, X, sex nullisomy, and lower overall sperm aneuploidy.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3116</offset><text>It is clear that a deficiency of paternal micronutrients could affect the development of offspring through epigenetic regulation. However, it is unclear at this time whether or not supplementation of vitamins such as folate can reduce congenital anomalies in men with an otherwise well-balanced diet. A prospective randomized control trial is necessary to adequately determine the role for male prenatal vitamins. Due to the lack of conclusive evidence, we cannot recommend the ubiquitous use of prenatal vitamins, in particular folate, in men attempting to plan a pregnancy with their female partner at this time.</text></passage><passage><infon key="fpage">617</infon><infon key="lpage">624</infon><infon key="name_0">surname:Correa-Villasenor;given-names:A</infon><infon key="name_1">surname:Cragan;given-names:J</infon><infon key="name_2">surname:Kucik;given-names:J</infon><infon key="name_3">surname:O'Leary;given-names:L</infon><infon key="name_4">surname:Siffel;given-names:C</infon><infon key="section_type">REF</infon><infon key="source">Birth defects research Part A, Clinical and molecular teratology</infon><infon key="type">ref</infon><infon key="volume">67</infon><infon key="year">2003</infon><offset>3731</offset><text>The Metropolitan Atlanta Congenital Defects Program: 35 years of birth defects surveillance at the Centers for Disease Control and Prevention</text></passage><passage><infon key="fpage">378</infon><infon key="name_0">surname:Dolk;given-names:H</infon><infon key="pub-id_pmid">19647606</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">374</infon><infon key="year">2009</infon><offset>3873</offset><text>What is the âprimaryâ prevention of congenital anomalies?</text></passage><passage><infon key="fpage">1832</infon><infon key="lpage">1835</infon><infon key="name_0">surname:Czeizel;given-names:AE</infon><infon key="name_1">surname:DudÃ¡s;given-names:I</infon><infon key="pub-id_pmid">1307234</infon><infon key="section_type">REF</infon><infon key="source">N Engl J Med</infon><infon key="type">ref</infon><infon key="volume">327</infon><infon key="year">1992</infon><offset>3935</offset><text>Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation</text></passage><passage><infon key="fpage">179</infon><infon key="lpage">183</infon><infon key="name_0">surname:Czeizel;given-names:AE</infon><infon key="pub-id_pmid">8882400</infon><infon key="section_type">REF</infon><infon key="source">American journal of medical genetics</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">1996</infon><offset>4037</offset><text>Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation</text></passage><passage><infon key="fpage">217</infon><infon key="name_0">surname:Tolarova;given-names:M</infon><infon key="pub-id_pmid">6123916</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1982</infon><offset>4140</offset><text>Periconceptional supplementation with vitamins and folic acid to prevent recurrence of cleft lip</text></passage><passage><infon key="fpage">2889</infon><infon key="name_0">surname:Lambrot;given-names:R</infon><infon key="name_1">surname:Xu;given-names:C</infon><infon key="name_2">surname:Saint-Phar;given-names:S</infon><infon key="name_3">surname:Chountalos;given-names:G</infon><infon key="name_4">surname:Cohen;given-names:T</infon><infon key="pub-id_pmid">24326934</infon><infon key="section_type">REF</infon><infon key="source">Nat Commun</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2013</infon><offset>4237</offset><text>Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes</text></passage><passage><infon key="fpage">112</infon><infon key="lpage">116</infon><infon key="name_0">surname:Kim;given-names:HW</infon><infon key="name_1">surname:Choi;given-names:YJ</infon><infon key="name_2">surname:Kim;given-names:KN</infon><infon key="name_3">surname:Tamura;given-names:T</infon><infon key="name_4">surname:Chang;given-names:N</infon><infon key="pub-id_pmid">21556224</infon><infon key="section_type">REF</infon><infon key="source">Nutrition research and practice</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2011</infon><offset>4349</offset><text>Effect of paternal folate deficiency on placental folate content and folate receptor alpha expression in rats</text></passage><passage><infon key="fpage">241</infon><infon key="lpage">248</infon><infon key="name_0">surname:Giri;given-names:AK</infon><infon key="pub-id_pmid">3540643</infon><infon key="section_type">REF</infon><infon key="source">Mutat Res</infon><infon key="type">ref</infon><infon key="volume">168</infon><infon key="year">1986</infon><offset>4459</offset><text>Mutagenic and genotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a review</text></passage><passage><infon key="fpage">628</infon><infon key="lpage">632</infon><infon key="name_0">surname:Beghin;given-names:D</infon><infon key="name_1">surname:Cournot;given-names:MP</infon><infon key="name_2">surname:Vauzelle;given-names:C</infon><infon key="name_3">surname:Elefant;given-names:E</infon><infon key="pub-id_pmid">21239747</infon><infon key="section_type">REF</infon><infon key="source">J Rheumatol</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2011</infon><offset>4540</offset><text>Paternal exposure to methotrexate and pregnancy outcomes</text></passage><passage><infon key="fpage">682</infon><infon key="lpage">688</infon><infon key="name_0">surname:Kaati;given-names:G</infon><infon key="name_1">surname:Bygren;given-names:LO</infon><infon key="name_2">surname:Edvinsson;given-names:S</infon><infon key="pub-id_pmid">12404098</infon><infon key="section_type">REF</infon><infon key="source">Eur J Hum Genet</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2002</infon><offset>4597</offset><text>Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period</text></passage><passage><infon key="fpage">1014</infon><infon key="lpage">1022</infon><infon key="name_0">surname:Young;given-names:SS</infon><infon key="name_1">surname:Eskenazi;given-names:B</infon><infon key="name_2">surname:Marchetti;given-names:FM</infon><infon key="name_3">surname:Block;given-names:G</infon><infon key="name_4">surname:Wyrobek;given-names:AJ</infon><infon key="pub-id_pmid">18353905</infon><infon key="section_type">REF</infon><infon key="source">Hum Reprod</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2008</infon><offset>4712</offset><text>The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men</text></passage></document></collection>
